Spyre Therapeutics (SYRE) Change in Acquisitions & Divestments (2016 - 2025)
Historic Change in Acquisitions & Divestments for Spyre Therapeutics (SYRE) over the last 10 years, with Q3 2025 value amounting to $99.2 million.
- Spyre Therapeutics' Change in Acquisitions & Divestments rose 2750.63% to $99.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $340.0 million, marking a year-over-year increase of 6804.55%. This contributed to the annual value of $246.0 million for FY2024, which is 51645.86% up from last year.
- Latest data reveals that Spyre Therapeutics reported Change in Acquisitions & Divestments of $99.2 million as of Q3 2025, which was up 2750.63% from $106.9 million recorded in Q2 2025.
- In the past 5 years, Spyre Therapeutics' Change in Acquisitions & Divestments registered a high of $106.9 million during Q2 2025, and its lowest value of $3.2 million during Q2 2023.
- Over the past 5 years, Spyre Therapeutics' median Change in Acquisitions & Divestments value was $30.7 million (recorded in 2021), while the average stood at $42.8 million.
- As far as peak fluctuations go, Spyre Therapeutics' Change in Acquisitions & Divestments plummeted by 8700.0% in 2023, and later soared by 168080.0% in 2024.
- Spyre Therapeutics' Change in Acquisitions & Divestments (Quarter) stood at $22.9 million in 2021, then fell by 19.26% to $18.5 million in 2022, then rose by 2.16% to $18.9 million in 2023, then surged by 230.94% to $62.5 million in 2024, then soared by 58.58% to $99.2 million in 2025.
- Its Change in Acquisitions & Divestments was $99.2 million in Q3 2025, compared to $106.9 million in Q2 2025 and $71.4 million in Q1 2025.